Correlation Between Algernon Pharmaceuticals and Nuvalent

Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Algernon Pharmaceuticals and Nuvalent, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Nuvalent.

Diversification Opportunities for Algernon Pharmaceuticals and Nuvalent

0.47

Correlation Coefficient

Algernon Pharmaceuticals  Nuvalent

Very weak diversification

The 3 months correlation between Algernon and Nuvalent is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Nuvalent go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and Nuvalent

Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 8.67 times less return on investment than Nuvalent. In addition to that, Algernon Pharmaceuticals is 2.71 times more volatile than Nuvalent. It trades about 0.0 of its total potential returns per unit of risk. Nuvalent is currently generating about 0.05 per unit of volatility. If you would invest  6,795  in Nuvalent on September 24, 2024 and sell it today you would earn a total of  1,627  from holding Nuvalent or generate 23.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.81%
Values	Daily Returns

Algernon Pharmaceuticals  vs.  Nuvalent

Algernon Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Algernon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Nuvalent

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Algernon Pharmaceuticals and Nuvalent

The main advantage of trading using opposite Algernon Pharmaceuticals and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.

The idea behind Algernon Pharmaceuticals and Nuvalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.